Cullinan Therapeutics Inc (CGEM)
25.29
+6.04
(+31.38%)
USD |
NASDAQ |
Apr 26, 10:37
Cullinan Therapeutics 1 Year Total Returns (Daily): 84.56% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 25, 2024 | 84.56% |
| April 24, 2024 | 76.87% |
| April 23, 2024 | 54.49% |
| April 22, 2024 | 44.86% |
| April 19, 2024 | 49.86% |
| April 18, 2024 | 75.85% |
| April 17, 2024 | 66.02% |
| April 16, 2024 | 72.85% |
| April 15, 2024 | 65.17% |
| April 12, 2024 | 67.88% |
| April 11, 2024 | 70.63% |
| April 10, 2024 | 66.11% |
| April 09, 2024 | 69.45% |
| April 08, 2024 | 69.15% |
| April 05, 2024 | 70.20% |
| April 04, 2024 | 60.23% |
| April 03, 2024 | 63.81% |
| April 02, 2024 | 66.08% |
| April 01, 2024 | 72.53% |
| March 28, 2024 | 62.60% |
| March 27, 2024 | 62.66% |
| March 26, 2024 | 59.66% |
| March 25, 2024 | 61.08% |
| March 22, 2024 | 58.96% |
| March 21, 2024 | 49.63% |
| Date | Value |
|---|---|
| March 20, 2024 | 42.74% |
| March 19, 2024 | 35.96% |
| March 18, 2024 | 34.39% |
| March 15, 2024 | 42.11% |
| March 14, 2024 | 48.07% |
| March 13, 2024 | 54.36% |
| March 12, 2024 | 55.56% |
| March 11, 2024 | 47.57% |
| March 08, 2024 | 51.81% |
| March 07, 2024 | 47.30% |
| March 06, 2024 | 57.07% |
| March 05, 2024 | 57.30% |
| March 04, 2024 | 59.13% |
| March 01, 2024 | 63.37% |
| February 29, 2024 | 63.60% |
| February 28, 2024 | 60.14% |
| February 27, 2024 | 61.55% |
| February 26, 2024 | 62.27% |
| February 23, 2024 | 63.64% |
| February 22, 2024 | 59.02% |
| February 21, 2024 | 55.32% |
| February 20, 2024 | 53.44% |
| February 16, 2024 | 64.83% |
| February 15, 2024 | 59.57% |
| February 14, 2024 | 55.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.87%
Minimum
Mar 31 2022
84.56%
Maximum
Apr 25 2024
-24.58%
Average
-28.87%
Median
1 Year Total Returns (Daily) Benchmarks
| Fate Therapeutics Inc | -35.82% |
| Viking Therapeutics Inc | 246.4% |
| Applied Therapeutics Inc | 214.8% |
| Oscar Health Inc | 210.1% |
| Edgewise Therapeutics Inc | 104.9% |